查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1856330

血液采集设备市场按产品类型、技术、材料、应用和最终用户划分 - 全球预测 2025-2032

Blood Collection Devices Market by Product Type, Technology, Material, Application, End Users - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，血液采集设备市场规模将达到 124.3 亿美元，复合年增长率为 6.09%。

关键市场统计数据
基准年 2024 77.4亿美元
预计年份：2025年 81.8亿美元
预测年份 2032 124.3亿美元
复合年增长率 (%) 6.09%

一份关于血液采集设备生态系统的全面发展方向报告，涵盖临床驱动因素、监管要求、生产製造复杂性以及策略重点。

血液采集设备领域处于临床需求、监管环境和製造复杂性的交会点，因此创新与可靠性必须并存。诊断技术的进步、对病人安全的日益重视以及医疗服务模式的转变，都提升了能够可靠采集和储存生物检体的设备的重要性。因此，价值链上的相关人员——製造商、临床实验室、采购人员和医疗服务提供者——都必须应对不断变化的技术标准、材料选择和营运预期。

对影响医疗设备设计、监管预期、供应链韧性和永续性优先事项的变革力量进行策略性检验

近年来，一场变革性的转变正在再形成血液采集设备的设计、製造和在医疗点的应用方式。自动化、封闭式系统设计和整合分析降低了分析前变异性，同时提高了中心实验室的侦测通量。同时，居家检测和即时检测的兴起，也凸显了对易于使用且稳定性强的设备的需求，迫使製造商重新思考人体工学和防腐剂的化学特性。

分析性地阐述了近期美国关税政策如何改变了筹资策略、生产地点、采购合约和产品开发决策。

美国新关税政策的实施将持续到2025年，对血液采集设备生态系统中的相关人员产生了多方面的影响，涵盖供应链、采购决策和产品成本结构。短期来看，依赖进口原材料和成品组件的製造商面临到岸成本上涨的压力，迫使他们重新谈判供应商合约并重新评估生产布局。这些成本动态促使采购团队仔细检视整体拥有成本（TCO），并评估近期价格调整是暂时的，还是预示着长期采购复杂性的体现。

透过深度细分主导的分析，揭示产品类型、技术选择、材料选择、临床应用和最终用户需求如何影响策略性产品和商业性决策。

这种深入的细分揭示了血液采集设备领域内不同产品类型和终端用户需求所受到的独特技术和商业性动态的影响。不同类型的产品在性能和监管方面各有侧重。血液采集袋需要强大的防漏性能、检验的灭菌方法和安全的标籤系统。血液采集针需要稳定的穿刺性能和生物相容性涂层，而注射器针头和真空针头则各自具有独特的操作和安全考虑。血液采集管涵盖了EDTA、肝素、血浆和血清管等各种特殊配方和添加剂管理。采血采血针强调易用性、最大限度减少疼痛和安全处置。

本书从细緻的区域观点，探讨了美洲、欧洲、中东和非洲以及亚太地区的动态变化将如何影响采购、监管、生产製造和临床应用。

区域动态持续影响全球血液采集设备市场的策略重点与竞争格局。在美洲，完善的捐血基础设施、先进的实验室网路和集中的采购管道，使得产品性能、可追溯性和供应商可靠性至关重要。该地区的医疗机构通常寻求能够支援快速完成监管文件、完善上市后监测、库存管理和临床培训的伙伴关係模式，并倾向于选择能够提供设备产品组合之外的综合服务的供应商。

竞争行为的策略整合表明，创新、监管掌控、供应链控制和服务差异化如何决定领导力和韧性。

主要企业之间的竞争源自于产品创新、监管专业知识、供应链控制以及超越设备本身的附加价值服务的综合作用。市场领导企业正投资于自动化平台和整合数位解决方案，以增强分析前可追溯性和实验室工作流程，而专业公司则专注于小众产品的卓越表现，例如新型试管化学配方或符合人体工学的采血针系统，以解决特定的临床痛点。设备製造商和诊断设备供应商之间的策略联盟日益普遍，从而能够提供捆绑式服务，优化从样本到结果的整个流程。

一系列切实可行的策略行动，高阶主管可以采取这些行动来增强供应链韧性、加速创新应用、提高监管应对力并巩固基于服务的差异化优势。

为维持成长并降低风险，产业领导者应采取协调一致的行动，将产品创新、供应链韧性和商业性执行结合。首先，透过对多家供应商进行资格认证并开发区域製造方案，实现筹资策略多元化，降低贸易中断和关税波动带来的风险。投资短期双重采购和策略性库存缓衝，可在实施长期在地化计画的同时保障业务连续性。其次，在临床和营运效益足以支持资本投入的情况下，加速采用自动化和封闭式系统设计，同时在低产量或分散式环境中提供经济高效的人工替代方案。

透明的调查方法概述：描述了支撑分析的关键相关人员参与、二次综合、三角验证实践和品质保证流程。

本分析所依据的研究结合了与相关人员的质性访谈、严谨的二手资料综合分析和资料三角验证，以确保获得平衡且切实可行的洞见。主要研究包括对临床实验室负责人、采购负责人、製造企业高管和法规事务专家进行结构化访谈，以获取关于设备性能、采购限制和市场推广驱动因素的第一手观点。这些访谈最终形成了一个产品类型、技术、材料、应用和最终用途的分类体系，从而能够进行反映实际业务状况的针对性分析。

这份简洁的报告综合阐述了策略重点、营运要务和精闢结论，明确了在整个生态系统中实现临床和商业性价值所需的行动。

摘要：在技术创新、不断变化的监管环境和供应链动态的驱动下，血液采集设备市场正经历显着的变革时期。这些因素正在再形成产品设计重点，加速高产量製造环境中自动化技术的应用，并凸显在贸易政策变化背景下，制定具有韧性的筹资策略的重要性。同时，根据产品类型、技术、材料、临床用途和最终用户背景进行细緻的市场细分，需要一种兼顾性能、成本和合规性的客製化方法。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 采用封闭式采血装置，最大限度地降低污染风险，确保样本完整性
  • 将RFID技术与智慧采血管集成，实现样本的自动化追踪与溯源
  • 开发一种超低容量儿科采血装置，以减少患者不适和样本浪费。
  • 利用微流体技术实现无针采血系统的兴起，可实现无痛采样。
  • 新冠病毒抗原和抗体血液采集试剂盒需求的成长推动了就地检验的需求。
  • 利用家用采血设备和远端医疗整合技术的远端患者监护解决方案日益普及
  • 监管机构对静脉采血安全和针刺预防日益重视，推动了器械创新。
  • 生物银行计画的扩展刺激了高通量血液采集自动化解决方案的需求。

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的血液采集设备市场

  • 血袋
  • 采血针
    • 针头
    • 真空针
  • 采血管
    • EDTA管
    • 肝素管
    • 电浆管
    • 血清管
  • 采血采血针

9. 按技术分類的采血设备市场

  • 自动采血装置
  • 手动采血装置

第十章 依材料分類的采血设备市场

  • 玻璃
  • 塑胶
  • 橡皮
  • 不銹钢

第十一章 依应用分類的采血设备市场

  • 诊断
  • 治疗

第十二章 依最终用户分類的血液采集设备市场

  • 捐血中心
  • 诊断中心和病理实验室
  • 医院和诊所

第十三章 各地区血液采集设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 按组别分類的采血设备市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国血液采集设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Abbott Laboratories
    • AdvaCare Pharma
    • Avanos Medical, Inc.
    • Avantor, Inc.
    • B. Braun SE
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Biosigma SpA
    • Cardinal Health, Inc.
    • Exelint International, Co.
    • Fresenius SE & Co. KGaA
    • Greiner AG
    • Haemonetics Corporation by GVS SpA
    • ICU Medical, Inc.
    • Kawasumi Laboratories America, Inc.
    • Lasany International
    • Medtronic PLC
    • Merit Medical Systems, Inc.
    • Nipro Corporation
    • Sarstedt AG & Co. KG
    • Sekisui Medical Co., Ltd.
    • Siemens Healthineers AG
    • Terumo Corporation
    • Thermo Fisher Scientific Inc.
Product Code: MRR-742BD517BE69

The Blood Collection Devices Market is projected to grow by USD 12.43 billion at a CAGR of 6.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.74 billion
Estimated Year [2025] USD 8.18 billion
Forecast Year [2032] USD 12.43 billion
CAGR (%) 6.09%

A comprehensive orientation to the blood collection device ecosystem that frames clinical drivers, regulatory demands, manufacturing complexity and strategic priorities

The blood collection device arena sits at the intersection of clinical need, regulatory scrutiny, and manufacturing complexity, creating a landscape where innovation and reliability must coexist. Advances in diagnostics, the growing emphasis on patient safety, and shifts in healthcare delivery models are elevating the strategic importance of devices that reliably obtain and preserve biological specimens. Consequently, stakeholders across the value chain-manufacturers, clinical laboratories, procurement professionals, and healthcare providers-must navigate evolving technical standards, material choices, and operational expectations.

Transitioning from traditional supply paradigms, industry participants are responding to demands for higher throughput, more consistent sample integrity, and enhanced user safety. Simultaneously, environmental considerations and circularity targets are prompting re-evaluation of materials and single-use formats. These combined pressures require organizations to balance short-term operational continuity with long-term strategic investments in automation, supply resilience, and regulatory preparedness. The introduction lays the groundwork for deeper analysis by framing the core drivers, risk vectors, and value opportunities that shape decision-making for manufacturers and institutional buyers alike.

A strategic examination of the transformative forces reshaping device design, regulatory expectations, supply chain resilience and sustainability priorities

Recent years have produced transformational shifts that are reshaping how blood collection devices are designed, manufactured, and deployed across care settings. Technological convergence is particularly notable: automation, closed-system designs, and integrated analytics are reducing pre-analytical variability while enabling higher throughput in centralized laboratories. At the same time, the rise of home-collection and point-of-care testing has amplified the need for user-friendly devices and robust stability profiles, prompting manufacturers to rethink ergonomics and preservative chemistry.

Regulatory and policy shifts are also catalyzing change. Heightened attention to adverse events, traceability requirements, and sterilization documentation has driven stronger post-market surveillance and more rigorous design controls. In parallel, supply chain realignment-motivated by both geopolitical uncertainty and a desire for regional self-sufficiency-has encouraged investments in localized manufacturing and dual-sourcing strategies. Moreover, sustainability commitments from hospitals and procurement consortia are influencing material selection and end-of-life considerations, nudging the industry toward alternatives to traditional plastics and greater use of recyclable or lower-impact components.

Together, these disruptive forces are fostering a competitive environment where speed to regulatory approval, the ability to demonstrate reliable clinical performance, and resilience of supply chains determine which companies will lead the next phase of industry evolution. As a result, organizations that integrate technological innovation with pragmatic supply and regulatory strategies are positioned to capture expanded clinical adoption and strengthen customer trust.

An analytical narrative on how recent United States tariff policies have reshaped sourcing strategies, production footprints, procurement contracts and product development decisions

The introduction of new tariff measures in the United States during 2025 has exerted layered effects across supply chains, procurement decisions, and product cost structures for stakeholders in the blood collection device ecosystem. In the immediate term, manufacturers that rely on imported raw materials or finished components experienced upward pressure on landed costs, which necessitated renegotiation of supplier contracts and reassessment of production footprints. These cost dynamics encouraged procurement teams to scrutinize total cost of ownership more closely, evaluating whether near-term price adjustments were temporary or indicative of longer-term sourcing complexity.

In response, many organizations accelerated diversification strategies by qualifying secondary suppliers, increasing inventory buffers for critical items, and exploring regional manufacturing partnerships that reduce exposure to cross-border duties. This strategic pivot carried operational trade-offs: while localization can mitigate tariff exposure, it may require significant capital expenditure or compromise on supplier specialization. Over time, the tariff environment also influenced product development decisions, encouraging designs that minimize reliance on imported subassemblies and that favor materials available from domestic or allied sources.

From a commercial perspective, buyers adjusted tender frameworks and procurement schedules to maintain supply continuity and price predictability. Meanwhile, companies with vertically integrated capabilities or established regional manufacturing hubs found opportunities to strengthen customer relationships by offering more predictable lead times and simplified compliance documentation. Looking ahead, the cumulative impacts of tariff-driven adjustments reinforce the importance of adaptable sourcing policies and proactive engagement with procurement partners to sustain margins and service levels in a shifting trade environment.

A deep segmentation-led analysis revealing how product types, technology choices, material selections, clinical applications and end-user needs shape strategic product and commercial decisions

Insightful segmentation illuminates the distinct technical and commercial dynamics that govern different product categories and end-user needs within the blood collection device space. Product type distinctions reveal divergent performance and regulatory priorities: Blood Bags require robust leak resistance, validated sterilization approaches, and secure labeling systems; Blood Collection Needles demand consistent puncture performance and biocompatible finishes, with syringe needles and vacuum needles each presenting unique handling and safety considerations; Blood Collection Tubes encompass specialized formulations and additive management across EDTA tubes, Heparin tubes, Plasma Blood tubes, and Serum tubes; and Blood Lancets emphasize ease of use, minimized pain, and safe disposal.

Technology segmentation differentiates opportunities and adoption pathways across automated blood collection devices and manual blood collection devices. Automation appeals to high-throughput laboratories and centralized blood banks seeking reduced variability and enhanced traceability, whereas manual devices remain prevalent in decentralized settings, smaller clinics, and certain point-of-care scenarios where cost and simplicity drive selection. Material choices further nuance product strategies, as glass offers inert properties ideal for some analytical workflows while plastic provides weight, breakage resistance, and cost advantages; rubber components influence sealing integrity and shelf life; and stainless steel dominates sharps that require precise machining and corrosion resistance.

Application-oriented segmentation separates diagnostic and therapeutic use cases, each imposing different validation, handling, and stability requirements. Diagnostics prioritize pre-analytical integrity and compatibility with downstream assays, while therapeutic applications may require specialized storage, compatibility with transfusion workflows, and traceability for clinical interventions. Finally, end-user segmentation-spanning blood donation centers, diagnostic centers and pathology laboratories, and hospitals and clinics-drives procurement patterns, capital allocation, and service-level demands. Blood donation centers prioritize donor safety and throughput, diagnostic centers emphasize compatibility with laboratory analyzers and sample stability, and hospitals and clinics require versatile devices that support a wide range of clinical procedures. Recognizing these layered segment distinctions helps firms tailor product portfolios, quality systems, and commercial approaches to address specific clinical, regulatory, and operational requirements effectively.

A nuanced regional perspective on how the Americas, Europe Middle East and Africa, and Asia-Pacific dynamics influence procurement, regulation, manufacturing and clinical adoption

Regional dynamics continue to influence strategic priorities and competitive positioning across the global landscape for blood collection devices. In the Americas, established blood donation infrastructures, sophisticated laboratory networks, and concentrated procurement channels create an environment where product performance, traceability, and supplier reliability are paramount. Providers in this region often demand rapid regulatory documentation, robust post-market surveillance, and partnership models that support inventory management and clinical training, which favors suppliers capable of delivering comprehensive service offerings alongside device portfolios.

Across Europe, the Middle East and Africa, regulatory heterogeneity and diverse healthcare delivery models produce a wide range of adoption curves and procurement behaviors. Western European markets emphasize stringent conformity assessment and environmental compliance, incentivizing premium devices and strong supplier certification paths. Meanwhile, markets within the broader region may prioritize cost-effective solutions and adaptable supply arrangements, and this diversity requires manufacturers to adopt flexible commercial strategies and regional regulatory expertise. Transitional healthcare systems in parts of the region present opportunities for targeted investments in training, supply chain development, and localized product customization.

The Asia-Pacific region exhibits rapid uptake of both centralized laboratory automation and decentralized testing models, driven by expanding healthcare access, rising screening initiatives, and growing local manufacturing capacity. Producers and distributors in Asia-Pacific are increasingly focused on scalability, cost-competitive manufacturing, and the ability to meet diverse regulatory regimes quickly. Additionally, Asia-Pacific serves as a critical production hub for many global players, and regional policies that encourage domestic manufacturing have prompted investments in capacity expansion, creating interdependencies between trade policies and supply availability worldwide. Together, these regional characteristics inform differentiated go-to-market tactics, regulatory planning, and manufacturing investments.

A strategic synthesis of competitive behavior showing how innovation, regulatory mastery, supply chain control and services-based differentiation determine leadership and resilience

Competitive dynamics among leading companies are driven by a combination of product innovation, regulatory expertise, supply chain control, and value-added services that extend beyond the device itself. Market leaders are investing in automation platforms and integrated digital solutions that enhance pre-analytical traceability and laboratory workflows, while specialized players focus on niche product excellence-such as novel tube chemistries or ergonomic lancet systems-that solve specific clinical pain points. Strategic partnerships between device manufacturers and diagnostic instrument providers are increasingly common, enabling bundled offerings that optimize sample-to-result pathways.

Consolidation activity and strategic alliances reflect a drive to capture complementary capabilities, scale regulatory operations, and secure supplier networks. In parallel, a subset of companies pursues regional manufacturing investments to reduce trade exposure and accelerate product registration, while others prioritize strengthening aftermarket services, including training, technical support, and consumable replenishment programs that increase customer stickiness. Product differentiation often hinges on documented stability claims, sterilization validation, and quality management certifications, which inform procurement decisions and reimbursement conversations. Ultimately, firms that align innovation with operational excellence and robust regulatory pathways are positioned to deepen market penetration and foster long-term customer partnerships.

A practical set of strategic actions for executives to strengthen supply resilience, accelerate innovation adoption, elevate regulatory readiness and embed services-based differentiation

Industry leaders should pursue coordinated actions that align product innovation, supply resilience, and commercial execution to sustain growth and mitigate risk. First, diversify sourcing strategies by qualifying multiple suppliers and developing regional manufacturing options to reduce exposure to trade disruptions and tariff volatility. Investing in near-term dual sourcing and strategic inventory buffers can protect continuity while longer-term localization plans are implemented. Second, accelerate adoption of automation and closed-system designs where clinical and operational benefits justify capital allocation, while simultaneously offering cost-effective manual alternatives for low-volume or decentralized settings.

Third, prioritize material innovation and sustainability by evaluating alternatives that preserve analytical integrity while reducing environmental impact; engage with lifecycle assessment frameworks to demonstrate value to procurement partners. Fourth, enhance regulatory readiness through proactive engagement with authorities, strengthened post-market surveillance, and expedited pathways for clearance or conformity assessment, thereby shortening time-to-adoption in regulated markets. Fifth, embed commercial support services-training, technical assistance, and consumables management-into customer contracts to differentiate offerings and improve retention. Finally, align R&D investments with real-world clinical needs by co-developing solutions with leading laboratories and healthcare providers, ensuring product designs reflect end-user workflows and deliver demonstrable improvements in sample quality and patient safety. Taken together, these steps will help organizations convert insight into operational advantage and durable customer relationships.

A transparent methodological overview explaining primary stakeholder engagement, secondary synthesis, triangulation practices and quality assurance processes that underpin the analysis

The research underpinning this analysis combined qualitative stakeholder engagement with rigorous secondary synthesis and data triangulation to ensure balanced, actionable insights. Primary research included structured interviews with clinical laboratory leaders, procurement officers, manufacturing executives, and regulatory affairs specialists to capture first-hand perspectives on device performance, sourcing constraints, and adoption drivers. These conversations informed the taxonomy used to disaggregate product types, technologies, materials, applications, and end-user contexts, enabling targeted analysis that reflects operational realities.

Secondary sources were reviewed to contextualize regulatory trends, material science developments, and trade policy impacts, with careful attention to public regulatory documents, standards bodies publications, and peer-reviewed clinical literature. Triangulation techniques were applied to reconcile differing viewpoints and validate key conclusions, while sensitivity checks were used to surface alternative interpretations. Quality assurance processes included expert peer review and internal methodological audits to confirm consistency in definitions, inclusion criteria, and analytical logic. The research acknowledges limitations inherent to rapidly changing policy environments and heterogeneous regional data, and therefore emphasizes scenario-based insights and actionable recommendations rather than precise numerical projections.

A concise concluding synthesis that crystallizes strategic priorities, operational imperatives and the actions needed to realize clinical and commercial value across the ecosystem

In summary, the blood collection device landscape is undergoing meaningful transformation driven by technological innovation, heightened regulatory expectations, and evolving supply chain dynamics. These forces are reshaping product design priorities, accelerating adoption of automation in high-volume settings, and elevating the importance of resilient sourcing strategies in the face of trade policy shifts. At the same time, segmentation nuances-across product types, technologies, materials, clinical applications, and end-user contexts-underscore the need for tailored approaches that balance performance, cost, and compliance.

Organizations that proactively align R&D, manufacturing strategy, and commercial support models will be better positioned to meet clinical needs and navigate regulatory complexity. Leaders should prioritize supply diversification, invest in automation where appropriate, pursue sustainable material pathways, and strengthen regulatory engagement to accelerate access. By translating these insights into concrete actions, manufacturers and institutional buyers can improve operational continuity, enhance sample integrity, and deliver measurable clinical value. The conclusion invites decision-makers to use these findings to inform strategic planning and to mobilize resources that capitalize on emerging opportunities while managing downside risks effectively.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of closed system blood collection devices to minimize contamination risk and ensure sample integrity
  • 5.2. Integration of smart blood collection tubes with RFID technology for automated sample tracking and traceability
  • 5.3. Development of ultra-low volume pediatric blood collection devices to reduce patient discomfort and sample waste
  • 5.4. Rise of needle-free blood collection systems leveraging microfluidic technologies for pain-free sampling
  • 5.5. Growth in COVID-19 antigen and antibody blood collection kits driving demand for point-of-care testing
  • 5.6. Surge in remote patient monitoring solutions using at-home blood collection devices and telehealth integration
  • 5.7. Increasing regulatory focus on phlebotomy safety and needlestick prevention driving device innovation
  • 5.8. Expansion of biobanking initiatives spurring demand for high-throughput blood collection automation solutions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Collection Devices Market, by Product Type

  • 8.1. Blood Bags
  • 8.2. Blood Collection Needles
    • 8.2.1. Syringe Needles
    • 8.2.2. Vacuum Needles
  • 8.3. Blood Collection Tubes
    • 8.3.1. EDTA Tubes
    • 8.3.2. Heparin Tubes
    • 8.3.3. Plasma Blood Tubes
    • 8.3.4. Serum Tubes
  • 8.4. Blood Lancets

9. Blood Collection Devices Market, by Technology

  • 9.1. Automated Blood Collection Devices
  • 9.2. Manual Blood Collection Devices

10. Blood Collection Devices Market, by Material

  • 10.1. Glass
  • 10.2. Plastic
  • 10.3. Rubber
  • 10.4. Stainless Steel

11. Blood Collection Devices Market, by Application

  • 11.1. Diagnostics
  • 11.2. Therapeutics

12. Blood Collection Devices Market, by End Users

  • 12.1. Blood Donation Centers
  • 12.2. Diagnostic Centers & Pathology Laboratory
  • 12.3. Hospitals & Clinics

13. Blood Collection Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Blood Collection Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Blood Collection Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. AdvaCare Pharma
    • 16.3.3. Avanos Medical, Inc.
    • 16.3.4. Avantor, Inc.
    • 16.3.5. B. Braun SE
    • 16.3.6. Becton, Dickinson and Company
    • 16.3.7. Bio-Rad Laboratories, Inc.
    • 16.3.8. Biosigma S.p.A.
    • 16.3.9. Cardinal Health, Inc.
    • 16.3.10. Exelint International, Co.
    • 16.3.11. Fresenius SE & Co. KGaA
    • 16.3.12. Greiner AG
    • 16.3.13. Haemonetics Corporation by GVS S.p.A.
    • 16.3.14. ICU Medical, Inc.
    • 16.3.15. Kawasumi Laboratories America, Inc.
    • 16.3.16. Lasany International
    • 16.3.17. Medtronic PLC
    • 16.3.18. Merit Medical Systems, Inc.
    • 16.3.19. Nipro Corporation
    • 16.3.20. Sarstedt AG & Co. KG
    • 16.3.21. Sekisui Medical Co., Ltd.
    • 16.3.22. Siemens Healthineers AG
    • 16.3.23. Terumo Corporation
    • 16.3.24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BLOOD COLLECTION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BLOOD COLLECTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD COLLECTION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 293. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 298. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 299. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 300. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 301. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 302. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 303. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 304. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 305. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 308. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION BLOOD COLLECTION